NCT03208296 2023-02-06Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)Ascend Biopharmaceuticals LtdPhase 1/2 Suspended24 enrolled